Venlafaxine is the Least Effective Medication for PTSD Among Those Listed
Among the medications you've listed, venlafaxine (Effexor) is explicitly not recommended for nightmare disorder associated with PTSD, making it the least effective option. 1
Evidence-Based Ranking from Least to Most Effective
Venlafaxine (Least Effective)
The 2018 American Academy of Sleep Medicine position paper explicitly states that venlafaxine is "not recommended" for the treatment of nightmare disorder, placing it in the same category as clonazepam as medications that should be avoided 1. This is a strong negative recommendation based on qualitative assessment of evidence and expert consensus, indicating it is "ineffective/harmful for most patients."
Remeron (Mirtazapine) - Limited Evidence
Mirtazapine is listed only as a second-line agent with "less evidence for usefulness in PTSD and carries a potentially greater side effect burden" 2. While a 2026 meta-analysis suggests some potential benefit when anxiety is prominent in depression, the evidence for PTSD specifically remains weak 3. It may have utility for sleep disturbances but lacks robust PTSD-specific efficacy data.
Prazosin - Downgraded Recommendation
Prazosin's status has become complicated. While older 2010 guidelines gave it a Level A recommendation for PTSD-associated nightmares 4, the 2018 AASM position paper downgraded it to "may be used" after a large 304-participant VA study showed no significant difference from placebo at 10 or 26 weeks 1. The task force noted that "many patients respond very well to prazosin" but acknowledged contradictory evidence, particularly when patients are on concurrent antidepressants (78% in the negative study) 1.
Prozac (Fluoxetine) - Moderate Evidence
Fluoxetine has FDA approval for PTSD treatment and demonstrated efficacy in reducing overall PTSD symptomatology, particularly arousal and numbing symptoms 5, 6. However, a 1994 study showed that "non-VA patients responded much better than VA patients," and improvement was characterized as "small" in some analyses 7, 6. It remains a reasonable first-line option but may not be as robust as other SSRIs.
Abilify (Aripiprazole) - Best Among These Options
Aripiprazole is listed as "may be used" for PTSD-associated nightmares in the 2018 AASM guidelines 1. A 2017 systematic review found that "aripiprazole resulted in significant improvements in the primary outcome, including Clinician-Administered PTSD Symptom Scale scores, in all but 1 study analyzed" 8. While not first-line, it has consistent evidence as monotherapy or adjunct therapy, with the most common discontinuations due to akathisia, anxiety, and insomnia 8.
Critical Clinical Context
The 2024 VA/DoD guidelines strongly recommend specific manualized psychotherapies (prolonged exposure, cognitive processing therapy, or EMDR) over pharmacotherapy as first-line treatment 9. When medications are used, paroxetine and sertraline (not on your list) have the strongest evidence and FDA approval, followed by venlafaxine in some guidelines—though this contradicts the AASM's negative recommendation for nightmare disorder specifically 9, 7.
Common Pitfall to Avoid
The evidence shows that venlafaxine demonstrated "large initial effects that decreased over time" in some studies 7, which may create a false impression of efficacy. However, the AASM's explicit "not recommended" designation for nightmare disorder—a core PTSD symptom—combined with its lack of sustained benefit makes it the clear least effective choice among your options 1.
For optimal PTSD treatment prioritizing morbidity, mortality, and quality of life: refer for trauma-focused psychotherapy first, and if pharmacotherapy is needed, consider sertraline or paroxetine over any of the medications you've listed 9, 7.